Gilde Healthcare Ii U.a. Cooperative, 10% Owner at Conatus Pharmaceuticals Inc (CNAT), sold 352 shares at $11.00 ($4K) on 2013-07-30, disclosed to the SEC on 2013-08-01.
Open-market sale of $4k CNAT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.